Therapy Areas: Vaccines
Biopharmaceutical company BioVaxys partner SpayVac for Wildlife scales up vaccine production in Madison facility
20 November 2024 - Biopharmaceutical company BioVaxys Technology Corp (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) and SpayVac for Wildlife Inc, a developer of humane fertility-control vaccines for animals, ...
Scancell reports promising SCOPE trial data for SCIB1 in advanced melanoma
18 November 2024 - Scancell Holdings plc (AIM: SCLP), a developer of immunotherapies for the treatment of cancer, on Monday reported positive data from the ongoing SCOPE trial for SCIB1 in combination...
Theragent and CellVax produce first batch of FK-PC101 autologous cancer vaccine for Phase 2 clinical trial
12 November 2024 - Advanced therapeutics contract development and manufacturing organisation (CDMO) Theragent Inc announced on Monday that its has produced the first batch of autologous cancer vaccine...
Transgene teams up with ProBioGen for individualised cancer vaccines
5 November 2024 - French biotechnology company Transgene (Euronext Paris:TNG) and ProBioGen, a contract development and manufacturing organisation (CDMO) in biologics, vaccines and viral vectors, anno...
Bio-Works Technologies AB secures LOI for vaccine manufacturing product
4 November 2024 - Biotechnology company Bio-Works Technologies AB announced on Monday that it has received a Letter of Intent for a EUR652,000 order of its WorkBeads affimAb, a product used in vaccine...
LakeShore Biopharma's Phase III YSJA Rabies Vaccine clinical trial receives Chinese NMPA approval
28 October 2024 - Biopharmaceutical company LakeShore Biopharma Co., Ltd (Nasdaq: LSB) announced on Friday that it has received approval from the National Medical Products Administration (NMPA) in Chi...